Some of the proposed genes have also been implicated in other cancers, for example gastric cancer (vimentin) [37], large B-cell lymphoma (nucleolin) [38], and pancreatic cancer (NAP1L1) [39]. This evidence concerns the gene VIM and pancreatic neoplasm.